A Novel Approach to Assessing In-Hospital Mortality After On-Pump Aortic Valve Replacement.

ABSTRACT:

Background

Surgical aortic valve replacement (SAVR) is the main treatment for severe aortic valve disease, the most common valvular heart disease worldwide.

Methods

We evaluated the in-hospital mortality risk factors and predictors following on-pump SAVR. We retrospectively reviewed data from consecutive patients treated at a tertiary center from 2022 to 2024, focusing on routine hematological data and inflammatory indexes, alongside established factors.

Results

Postoperative vasoactive-inotropic score (VIS) (OR 1.058, CI 95%: 1.007-1.112), platelet count (OR 1.033, CI 95%: 1.002-1.064), lymphocyte counts (OR 3.532, CI 95%: 1.507-8.278), and perioperative fresh frozen plasma transfusion (OR 1.335, CI 95%: 1.068-1.669) were independent risk factors for SAVR in-hospital

SUBMITTER: Dragan A 

PROVIDER: S-EPMC12653218 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature